Alkion Terminals, LBC Tank Terminals and Sogestran Announce the Signing of Two Sale & Purchase Agreements for Eight Tank Terminals in France, Spain and Portugal
Alkion Terminals (Alkion) and LBC Tank Terminals (LBC) today announced the signing of an agreement in which Alkion will acquire the 50% shareholding of LBC in LBC Sogestrol and the full ownership of 4 tank terminals in France (Bayonne, Le Havre, Marseille, Nantes), 2 tank terminals in Spain (Cartagena, Santander) and 1 tank terminal in Portugal (Lisbon).
In parallel, Alkion and Sogestran today announced the signing of an agreement in which Alkion will acquire the 50% shareholding of Sogestran in LBC Sogestrol. Following the concomitant completion of the transactions, Alkion will be the sole owner and operator of LBC Sogestrol, a world-class tank terminal in Le Havre, France.
Established in 2016 as a new independent tank terminal operator focusing
in Western Europe, Alkion is creating a network of tank terminals that
perform a primary role in the hydrocarbon downstream value chain.
Currently Alkion owns a tank terminal in Amsterdam. Post completion of
the transactions with LBC and Sogestran Alkion will be operating well
over 1 million cubic meter of tank capacity at 9 terminals in 4
countries.
The eight new terminal additions to the Alkion portfolio
are located in key locations offering high quality service to an
extensive portfolio of long term customers based on an excellent
reputation. Alkion Terminals intends to invest further in improving and
expanding the assets to provide its existing and new customers a
world-class service.
The transactions are subject to customary regulatory approvals.
Rutger van Thiel, CEO at Alkion Terminals and Partner at Coloured Finches, stated: “We are delighted to welcome the customers and terminal staff to Alkion Terminals. We look forward to continue serving the European petroleum and chemical industry at our nine Alkion terminals and to pursue our ambition to further expand the Alkion network into Europe.
Vincent Levita, Founder and CEO of InfraVia, declared: “The acquisitions are a true milestone in building Alkion into a European wide provider of independent tank storage services to the petroleum and chemical industry. We are excited to take over these high quality assets and we look forward to supporting the further growth of the platform”.
Walter Wattenbergh, Group CEO of LBC Tank Terminals says: “I Congratulate Alkion and Infravia with the expansion of their business. We are very happy to know our staff and terminals in France, Spain and Portugal are in good hands with Alkion. With the support of our Shareholders LBC Tank Terminals will further focus on our hub terminal strategy which we are confident will ensure a sustainable future for LBC and all its employees. As one team we will continue to ensure that there is no such thing as a dangerous product, as long as it is under our care!”.
Advisors
- DC Advisory (financing), Herbert Smith Freehills (legal), KPMG (tax & accounting) and Nexant (commercial) advised Alkion Terminals on the transaction.
- Lazard (financing) and Linklaters (legal) advised LBC on the transaction.
- Sekri Valentin Zerrouk (legal) advised Sogestran.
About Alkion Terminals
Alkion Terminals is a partnership between infrastructure investor InfraVia Capital Partners and Dutch energy expert Coloured Finches. Established in 2016 Alkion Terminals combines the tank storage industry expertise and hands-on operational expertise of Coloured Finches with the dry powder and financing expertise of InfraVia to acquire, upgrade and optimize liquid bulk terminals in Europe. Following the completion of the transactions Alkion Terminals will be owning and operating 9 terminals in the Netherlands, France, Spain and Portugal.
About LBC Tank Terminals
LBC Tank Terminals is one of the largest global operators of bulk liquid storage facilities for chemical petroleum products and base oil products. LBC owns and operates a global network of terminals at key locations in the United States, Europe and China, while offering loading / unloading services for all modes of transportation.
More information is available at www.lbctt.com
About InfraVia Capital Partners
InfraVia Capital Partners is an investment manager dedicated to the infrastructure sector. InfraVia Capital Partners manages € 1.7 billion of assets through three infrastructure funds, which are all positioned as long term investors across the infrastructure sectors in Europe.
About Coloured Finches
Coloured Finches is a Dutch company established by former CEOs from the oil downstream industry. The independent group is active in the integrated downstream business and has extensive knowledge and experience in owning and operating storage terminals.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170427005951/en/
Contact information
PRESS CONTACTS
ALKION TERMINALS
Rutger VAN
THIEL, +31 (0)6 83 59 06 76
CEO
rvthiel@alkion.com
or
INFRAVIA
Vincent
LEVITA, +33 (0)1 40 68 17 38
Founder & CEO
vlevita@infraviacapital.com
or
Feten
BEN HARIZ
+33 (0)1 44 82 66 77
fbenhariz@agencefargo.com
or
LBC
TANK TERMINALS
Christina Schosser, +32 (0)15 28 73 10
c-schosser@lbctt.com
or
SOGESTRAN
François
HAAS, +33 2 32 79 26 58
Sogestran Board member
President of
Sogestrol
Francois.haas@sogestran.fr
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release
Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release
Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom